Anidulafungin treatment of candidal central nervous system infection in a murine model

Cheol In Kang, Mark S. Rouse, Jayawant Mandrekar, James M. Steckelberg, Robin Patel

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We established a murine model of Candida albicans central nervous system (CNS) infection and evaluated the efficacy of anidulafungin. Ten milligrams/kg/day anidulafungin, amphotericin B, or voriconazole signifi-cantly reduced mortality and fungal burden in brain tissue, although amphotericin B and 10 mg/kg/day anidulafungin reduced fungal burden in brain tissue to a greater extent than did voriconazole. This suggests a potential role for anidulafungin in the treatment of candidal CNS infection.

Original languageEnglish (US)
Pages (from-to)3576-3578
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume53
Issue number8
DOIs
StatePublished - Aug 2009

Fingerprint

anidulafungin
Central Nervous System Infections
Amphotericin B
Brain
Candida albicans
Mortality

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this

Anidulafungin treatment of candidal central nervous system infection in a murine model. / Kang, Cheol In; Rouse, Mark S.; Mandrekar, Jayawant; Steckelberg, James M.; Patel, Robin.

In: Antimicrobial Agents and Chemotherapy, Vol. 53, No. 8, 08.2009, p. 3576-3578.

Research output: Contribution to journalArticle

@article{93e963219df74af48ac4d1b0cda0885c,
title = "Anidulafungin treatment of candidal central nervous system infection in a murine model",
abstract = "We established a murine model of Candida albicans central nervous system (CNS) infection and evaluated the efficacy of anidulafungin. Ten milligrams/kg/day anidulafungin, amphotericin B, or voriconazole signifi-cantly reduced mortality and fungal burden in brain tissue, although amphotericin B and 10 mg/kg/day anidulafungin reduced fungal burden in brain tissue to a greater extent than did voriconazole. This suggests a potential role for anidulafungin in the treatment of candidal CNS infection.",
author = "Kang, {Cheol In} and Rouse, {Mark S.} and Jayawant Mandrekar and Steckelberg, {James M.} and Robin Patel",
year = "2009",
month = "8",
doi = "10.1128/AAC.00646-09",
language = "English (US)",
volume = "53",
pages = "3576--3578",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - Anidulafungin treatment of candidal central nervous system infection in a murine model

AU - Kang, Cheol In

AU - Rouse, Mark S.

AU - Mandrekar, Jayawant

AU - Steckelberg, James M.

AU - Patel, Robin

PY - 2009/8

Y1 - 2009/8

N2 - We established a murine model of Candida albicans central nervous system (CNS) infection and evaluated the efficacy of anidulafungin. Ten milligrams/kg/day anidulafungin, amphotericin B, or voriconazole signifi-cantly reduced mortality and fungal burden in brain tissue, although amphotericin B and 10 mg/kg/day anidulafungin reduced fungal burden in brain tissue to a greater extent than did voriconazole. This suggests a potential role for anidulafungin in the treatment of candidal CNS infection.

AB - We established a murine model of Candida albicans central nervous system (CNS) infection and evaluated the efficacy of anidulafungin. Ten milligrams/kg/day anidulafungin, amphotericin B, or voriconazole signifi-cantly reduced mortality and fungal burden in brain tissue, although amphotericin B and 10 mg/kg/day anidulafungin reduced fungal burden in brain tissue to a greater extent than did voriconazole. This suggests a potential role for anidulafungin in the treatment of candidal CNS infection.

UR - http://www.scopus.com/inward/record.url?scp=67749084491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67749084491&partnerID=8YFLogxK

U2 - 10.1128/AAC.00646-09

DO - 10.1128/AAC.00646-09

M3 - Article

C2 - 19506064

AN - SCOPUS:67749084491

VL - 53

SP - 3576

EP - 3578

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 8

ER -